PP
Phio Pharmaceuticals Corp.
SEC filingBiotechnology · King of Prussia, PA
Amount raised$1.4Msold at filing
Total offering$25.9M$24.5M still open
Investors in the raise5count reported to the SEC
FiledNov 12, 2025first sale Nov 4, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Curtis A. Lockshin, Ph.D.Director
Patricia A. BradfordDirector
Robert J. BittermanDirector, Executive Officer
Lisa H. CarsonExecutive Officer
David H. DemingDirector
Jonathan A. FreemanDirector
Executive officers, directors and promoters as listed on the Form D.